Skip to main content
. 2011 Feb 18;13(1):R28. doi: 10.1186/ar3254

Table 5.

Summary of the higher-quality evidence for treating impairments and function in individuals with hand osteoarthritis

Treatment goals Joints Intervention LOE Quality: score on PEDro scale Outcome tool SMD (95% CI)
Pain reduction CMC + IP Splints: long-term night use (>12 months) [31] 1b 8 VAS 4.24 (3.52, 4.97)
Improve hand function CMC + IP Splints: Short-term night use (1 month) [31] 1b 8 CHFS 1.10 (0.68, 1.52)
Splints: Long-term night use (>12 months) [31] 3.73 (3.05,4.40)
CMC + IP Joint protection education plus home exercise program [34] 2b 6 HAQ NA, P < 0.05
Improve hand strength CMC + IP Splints: Short-term night use (1 month) [31] 1b 8 Pinch (Dy) 0.9 (0.5, 1.3)
Splints: Long-term night use (>12 months) [31] 1.2 (0.8, 1.6)
CMC + IP Joint protection education plus home exercise program [34] 2b 6 Grip (V) 4.5 (3.3, 5.7)
Improve range of motion CMC + IP Splints: Long-term night use (>12 months) [31] 1b 8 KI 3.30 (2.7, 3.9)
CMC Low-level laser (20 minutes/session × 3 sessions/week) [24] 1b 10 G NA, P = 0.011
Decrease stiffness - - - - - -

CHFS, Cochin hand functional scale; CI, confidence intervals for continuous variables; CMC, carpometacarpal; Dy, dynamometer(s); G, goniometer (s); HAQ, Health Assessment Questionnaire; IP, interphalangeal; KI, Kapandji index (thumb opposition); LOE, level of evidence (Oxford); NA, standardized mean difference not estimable; PEDro, Physiotherapy Evidence Database; SMD, standardized mean difference; V, vigorimeter VAS, visual analogue scale.